IL-6 inhibits the targeted modulation of PDCD4 by miR-21 in prostate cancer

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Dong, Biao ^a,b   Shi, Zhihao ^c   Wang, Jiaping ^a   Wu, Jing ^a   Yang, Zhaoqing ^d   Fang, Kewei ^a,b  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b Design Institute of Yunnan Province   (China)

^c Jinan Military Region   (China)

^d INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; MICRORNA 21; PROSTATE SPECIFIC ANTIGEN; APOPTOSIS REGULATORY PROTEIN; MESSENGER RNA; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; CANCER CELL LINE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; PDCD4 GENE; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN FUNCTION; PROTEIN RNA BINDING; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; DRUG EFFECTS; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TUMOR CELL LINE;

APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-6; MALE; MICRORNAS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; RNA-BINDING PROTEINS; TRANSFECTION;

EID: 84941985555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134366     Document Type: Article

References (28)

1. Chun JY, Nadiminty N, Dutt S, Lou W, Yang JC, Kung HJ, et al. Interleukin-6 regulates androgen synthesis in prostate cancer cells. Clin Cancer Res. 2009; 15(15): 4815-22. doi: 10.1158/1078-0432.CCR- 09-0640 PMID: 19638459
2. Drachenberg DE, Elgamal AA, Rowbotham R, Peterson M, Murphy GP. Circulating levels of interleukin- 6 in patients with hormone refractory prostate cancer. Prostate. 1999; 41(2):127-33. PMID: 10477909
3. Iacopino F, Pinto F, Bertaccini A, Calarco A, Proietti G, Totaro A, et al. Soluble E-cadherin and IL-6 serum levels in patients affected by prostate cancer before and after prostatectomy. Oncol Rep. 2012; 28(1):370-4. doi: 10.3892/or.2012.1785 PMID: 22552350
4. Shariat SF, Kattan MW, Traxel E, Andrews B, Zhu K, Wheeler TM, et al. Association of pre- and postoperative plasma levels of transforming growth factor beta(1) and interleukin 6 and its soluble receptor with prostate cancer progression. Clin Cancer Res. 2004; 10(6):1992-9. PMID: 15041717
5. Masuda M, Wakasaki T, Suzui M, Toh S, Joe AK, Weinstein IB. Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers? Curr Cancer Drug Targets. 2010; 10 (1):117-26. PMID: 20088788
6. Colombatti M, Grasso S, Porzia A, Fracasso G, Scupoli MT, Cingarlini S, et al. The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. PLoS One. 2009; 4(2):e4608. doi: 10.1371/journal.pone.0004608 PMID: 19242540
7. Hilliard A, Hilliard B, Zheng SJ, Sun H, Miwa T, Song W, et al. Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death4. J Immunol. 2006; 177(11):8095-102. PMID: 17114484
8. Zakowicz H, Yang HS, Stark C, Wlodawer A, Laronde-Leblanc N, Colburn NH. Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor PDCD4 and eIF4GI. RNA. 2005; 11(3):261-74. PMID: 15661843
9. Ambros V. The functions of animal microRNAs. Nature. 2004; 431(7006):350-5. PMID: 15372042
10. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol. 2009; 174(4):1131-8. doi: 10.2353/ajpath. 2009.080794 PMID: 19264914
11. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005; 65(14):6029-33. PMID: 16024602
12. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008; 14(11):2348-60. doi: 10.1261/rna.1034808 PMID: 18812439
13. Dillhoff M, Liu J, FrankelW, Croce C, Bloomston M. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg. 2008; 12(12):2171-6. doi: 10.1007/ s11605-008-0584-x PMID: 18642050
14. Shi GH, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, et al. Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC-3 cells. Acta Pharmacol Sin. 2010; 31(7):867-73. doi: 10.1038/aps.2010.48 PMID: 20581857
15. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med. 2009; 13(1):39-53. doi: 10.1111/j.1582-4934.2008.00556.x PMID: 19175699
16. Li T, Li D, Sha J, Sun P, Huang Y. MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochem Biophys Res Commun. 2009; 383(3):280-5. doi: 10.1016/j.bbrc.2009.03.077 PMID: 19302977
17. Yao Q, Xu H, Zhang QQ, Zhou H, Qu LH. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun. 2009; 388(3):539-42. doi: 10.1016/j.bbrc.2009.08.044 PMID: 19682430
18. Ma G, Zhang H, Dong M. Expression of programmed cell death 4 (PDCD4) related to tumor differentiation in human cancers of digestive system. Chin J Cancer Prev Treat. 2007; 14(4):249-253.
19. Zhang H, Ozaki I, Mizuta T, Hamajima H, Yasutake T, Eguchi Y, et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene. 2006; 25(45):6101-12. PMID: 16682950
20. Wen YH, Shi X, Chiriboga L, Matsahashi S, Yee H, Afonja O. Alterations in the expression of PDCD4 in ductal carcinoma of the breast. Oncol Rep. 2007; 18(6):1387-93. PMID: 17982621
21. Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, et al. Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China. J Transl Med. 2008; 6(1):32.
22. Yu Y, Kanwar SS, Patel BB, Oh PS, Nautiyal J, Sarkar FH, et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGF?R2) in colon cancer cells. Carcinogenesis. 2012; 33(1):68-76. doi: 10.1093/carcin/bgr246 PMID: 22072622
23. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008; 27(15):2128-36. PMID: 17968323
24. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, Ruan Q, et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol. 2010; 11(2):141-7. doi: 10.1038/ni.1828 PMID: 19946272
25. Lu Z, Liu M, Stribinskis V, Klinge CM, Ramos KS, Colburn NH, et al. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene. 2008; 27(31):4373-9. doi: 10. 1038/onc.2008.72 PMID: 18372920
26. Giri D, Ozen M, Ittmann M. Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol. 2001, 159(6):2159-65. PMID: 11733366
27. Lin DL, Whitney MC, Yao Z, Keller ET. Interleukin-6 induces androgen responsiveness in prostate cancer cells through up-regulation of androgen receptor expression. Clin Cancer Res. 2001; 7(6):1773-81. PMID: 11410519
28. Ribas J, Lupold SE. The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer. Cell Cycle. 2010; 9(5):923-9. PMID: 20160498